ilShinbiobase Co. Ltd (068330) — Cash Flow Quality Index
ilShinbiobase Co. Ltd (068330) has a Cash Flow Quality Index of 3.55x as of March 2026. Operating cash flow of ₩3.46 Billion exceeds net income of ₩975.10 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of ilShinbiobase Co. Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ilShinbiobase Co. Ltd Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for ilShinbiobase Co. Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 068330 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year earnings quality comparison for ilShinbiobase Co. Ltd. For live market cap and the full company financial profile, see market cap of ilShinbiobase Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.10x | ₩5.27 Billion | ₩4.79 Billion | ▲ +1.6% |
| 2024 | 1.08x | ₩4.12 Billion | ₩3.81 Billion | ▲ +13.7% |
| 2023 | 0.95x | ₩5.92 Billion | ₩6.23 Billion | ▲ +37.0% |
| 2022 | 0.69x | ₩2.65 Billion | ₩3.82 Billion | ▼ -35.8% |
| 2021 | 1.08x | ₩6.74 Billion | ₩6.24 Billion | ▼ -4.8% |
| 2020 | 1.13x | ₩4.50 Billion | ₩3.97 Billion | ▼ -4.9% |
| 2019 | 1.19x | ₩5.55 Billion | ₩4.65 Billion | ▼ -22.7% |
| 2018 | 1.54x | ₩4.88 Billion | ₩3.16 Billion | ▲ +53.6% |
| 2017 | 1.00x | ₩2.11 Billion | ₩2.10 Billion | ▼ -10.1% |
| 2016 | 1.12x | ₩3.01 Billion | ₩2.69 Billion | ▲ +957.5% |
| 2015 | 0.11x | ₩270.22 Million | ₩2.56 Billion | ▼ -94.0% |
| 2014 | 1.77x | ₩3.33 Billion | ₩1.88 Billion | — |